Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model

被引:6
作者
Cloutier, Renee M. [1 ]
Cole, Evan S. [2 ]
Mcdonough, Brianna L. [1 ]
Lomauro, Daniel A. [1 ]
Miller, John P. [1 ]
Talbert, Abigail L. [1 ]
Bear, Todd M. [3 ]
Bridges, Nora C. [4 ]
Foulds, Abigail L. [3 ]
Taber, Rachel [3 ]
Gordon, Adam J. [5 ]
Cochran, Gerald T. [5 ]
Kmiec, Julie [6 ]
Donohue, Julie M. [2 ]
Kelley, David [7 ]
Didomenico, Ellen [8 ]
Adair, Dale [7 ]
Pringle, Janice L. [1 ,9 ]
机构
[1] Univ Pittsburgh, Program Evaluat & Res Unit, Sch Pharm, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Hlth Policy & Management, Grad Sch Publ Hlth, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Behav & Community Hlth Sci, Grad Sch Publ Hlth, Pittsburgh, PA USA
[4] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[5] Univ Utah, Program Addict Res Clin Care Educ & Advocacy, Sch Med, Salt Lake City, UT USA
[6] Univ Pittsburgh, Dept Psychiat, Sch Med, Pittsburgh, PA USA
[7] Penn Dept Human Serv, Off Med Assistance Programs, Harrisburg, PA USA
[8] Penn Dept Drug & Alcohol Programs, Harrisburg, PA USA
[9] Univ Pittsburgh, Program Evaluat & Res Unit, Sch Pharm, Off Baum, Floor 2 5607 Baum Blvd, Pittsburgh, PA 15206 USA
来源
IMPLEMENTATION RESEARCH AND PRACTICE | 2023年 / 4卷
基金
美国医疗保健研究与质量局;
关键词
health services accessibility; opiate substitution treatment/methods; opioid-related disorders/diagnosis; opioid-related disorders/drug therapy; Pennsylvania; quality of health care/organization & administration; rural health services; the United States; SUBSTANCE USE DISORDERS; UNITED-STATES; BARRIERS; ADULTS;
D O I
10.1177/26334895231152808
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Access to providers and programs that provide medications for opioid use disorder (MOUD) remains a systemic barrier for patients with opioid use disorder (OUD), particularly if they live in rural areas. The Rural Access to Medication Assisted Treatment (MAT) in Pennsylvania Project (Project RAMP) addressed this problem with a multisystem partnership that recruited, trained, and supported rural primary care providers to provide MOUD and implement an integrated care model (ICM) for patients with OUD. Given the demonstrated efficacy of Project RAMP, this article summarizes our recruitment strategies, including feasibility concerns for further expansion into other regions. Methods The approach for recruiting implementation sites included two phases: partner outreach and site identification. Once recruited, the Systems Transformation Framework guided planning and implementation activities. Recruitment and implementation activities were assessed with implementation trackers and evaluated by providers via key informant interviews (KIIs). Results Project RAMP recruited 26 primary care practices from 13 counties, including nine health systems and two private practice groups-exceeding the original target of 24 sites. There was a median of 49 days from first contact to project onboarding. A total of 108 primary care practices spanning 22 health systems declined participation. Findings from the KIIs highlighted the value of engaging PCPs by connecting to a shared vision (i.e., improving the quality of patient care) as well as addressing perceived participation barriers (e.g., offering concierge technical assistance to address lack of training or resources). Conclusion Findings highlight how successful recruitment activities should leverage the support of health system leadership. Findings also emphasize that aiding recruitment and engagement efforts successfully addressed prescribers' perceived barriers to providing MOUD as well as facilitating better communication among administrators, PCPs, behavioral health professionals, care managers, and patients.
引用
收藏
页数:12
相关论文
共 53 条
[31]  
Mackey K., 2009, Evidence Synthesis Program, VA ESP Project #09-009
[32]  
Madras Bertha K, 2020, NAM Perspect, V2020, DOI 10.31478/202004b
[33]   Confidentiality protections versus collaborative care in the treatment of substance use disorders [J].
Manuel J.K. ;
Newville H. ;
Larios S.E. ;
Sorensen J.L. .
Addiction Science & Clinical Practice, 8 (1)
[34]   Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review [J].
Marchand, Kirsten ;
Beaumont, Scott ;
Westfall, Jordan ;
MacDonald, Scott ;
Harrison, Scott ;
Marsh, David C. ;
Schechter, Martin T. ;
Oviedo-Joekes, Eugenia .
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2019, 14 (01)
[35]   Evaluation of electronic recruitment efforts of primary care providers as research subjects during the COVID-19 pandemic [J].
Mazurenko, Olena ;
Sanner, Lindsey ;
Apathy, Nate C. ;
Mamlin, Burke W. ;
Menachemi, Nir ;
Adams, Meredith C. B. ;
Hurley, Robert W. ;
Erazo, Saura Fortin ;
Harle, Christopher A. .
BMC PRIMARY CARE, 2022, 23 (01)
[36]   Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group [J].
McLellan, A. Thomas ;
Starrels, Joanna L. ;
Tai, Betty ;
Gordon, Adam J. ;
Brown, Richard ;
Ghitza, Udi ;
Gourevitch, Marc ;
Stein, Jack ;
Oros, Marla ;
Horton, Terry ;
Lindblad, Robert ;
McNeely, Jennifer .
PUBLIC HEALTH REVIEWS, 2013, 35 (02)
[37]   Drug dependence, a chronic medical illness - Implications for treatment, insurance, and outcomes evaluation [J].
McLellan, AT ;
Lewis, DC ;
O'Brien, CP ;
Kleber, HD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (13) :1689-1695
[38]   Inside help: An integrative review of champions in healthcare-related implementation [J].
Miech, Edward J. ;
Rattray, Nicholas A. ;
Flanagan, Mindy E. ;
Damschroder, Laura ;
Schmid, Arlene A. ;
Damush, Teresa M. .
SAGE OPEN MEDICINE, 2018, 6
[39]   Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population [J].
Morgan, Jake R. ;
Schackman, Bruce R. ;
Leff, Jared A. ;
Linas, Benjamin P. ;
Walley, Alexander Y. .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2018, 85 :90-96
[40]  
Natl Acad Sci Engn Med, 2019, MEDICATIONS FOR OPIOID USE DISORDER SAVE LIVES, P1, DOI 10.17226/25310